p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
about
The desmosomeDesmosomes in acquired diseasePreclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgarisPemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanismInhibition of Rho A activity causes pemphigus skin blistering.Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptorPeptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus.Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiologyIncreased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigusp38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis.Mechanisms of Autoantibody-Induced Pathology.Desmoglein 3, via an interaction with E-cadherin, is associated with activation of SrcLoss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies.Protein kinase D as a potential new target for cancer therapy.Tyrosine kinases in inflammatory dermatologic disease.p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.Signaling dependent and independent mechanisms in pemphigus vulgaris blister formationDesmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.Desmoglein as a target in skin disease and beyond.The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.Structure, function, and regulation of desmosomes.The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?Update on fogo selvagem, an endemic form of pemphigus foliaceusPeptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blisteringRegulation of Hsp27 and Hsp70 expression in human and mouse skin construct models by caveolae following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfidePemphigus antibody induced phosphorylation of keratinocyte proteins.The desmosome and pemphigus.A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysisp38 MAPK signaling in oral-related diseases.Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skinSeeking approval: present and future therapies for pemphigus vulgarisAdvances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin.Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies.Setting the target for pemphigus vulgaris therapy.Apoptotic pathways in pemphigus.Pemphigus autoimmunity: hypotheses and realities.Urban legends: pemphigus vulgaris.Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.
P2860
Q24656653-3D27D6A0-0C29-4338-88C4-5A37F12175D8Q27025901-99A8473A-623B-43FB-A73E-99EC33554424Q27311634-5C8A6667-B5D8-425D-9E24-B4C0FE051695Q30482467-B98C73A5-B789-4560-A171-7EBEAA885F90Q33264769-F42C26AA-8DF3-4C90-9B1B-3FEE55B64670Q33400239-4FB41A87-7420-4024-8343-9FE9218A5500Q33402377-E0945A0A-0A8A-4B07-9A7A-D9CFF55DF3F2Q33498310-089E9108-FA82-4C38-AA44-07FA23BF52BCQ33662058-EF5F2DA1-56DD-415E-BC99-2C1BD9451EA7Q33702474-1C00B3CF-4DAE-4C52-BA81-101B7BF1E572Q33726526-E5B231A2-6477-47BD-AACE-D8259D3393F0Q33740580-A97B5A0F-199B-40B4-BF6C-248CD487C462Q33769643-5437B750-DCCF-42AE-836D-FF12810EAD9FQ33997044-86EA6C28-681D-476D-AA5B-E9022F20EBD3Q34164040-E8925A72-1D76-489F-AD16-ACC7BDC6A0A2Q34166503-43E7DDEF-2B6A-424E-8A11-FF1CE6BF42A5Q34488972-F6D0D13B-300F-4F77-95C1-CADC5E516F2EQ34506586-39F43A2A-F45B-4160-A55F-B44CC8945F9AQ34551718-53BDC1F2-C326-499A-B5EF-9070E26523C0Q34634515-AFDA64B4-95E9-4C94-807A-C112B20F1EB6Q34868949-2AC78813-C99F-4523-9793-DA2062A6CF4AQ35107942-4C956172-C3FC-41DE-A028-6D4B07E8AD20Q35235788-A752C0D4-BBCA-4C3E-AA6D-3459A19A666EQ35834295-D57B5B00-39BB-48EB-BB57-DC24C4EE5FB8Q36580336-9D908A57-66CD-4707-A8E3-03F1EE701E6DQ36638914-DE4C0CBE-8ED7-4AA1-B258-E6EBEEF414AFQ36652509-06471C59-4E58-43E2-8AB2-F794C740279BQ36700065-1EC3BF3D-7FDE-4785-8E0D-95769A740703Q36725116-05FF4BF3-C63E-4CB5-BFA1-7B660AD6FE4EQ36919722-1AC6A716-60B5-48AA-9D34-CB49422B1F7BQ37061072-5E975E67-411C-41C5-AFE5-79BF6695125CQ37157777-8E3E309D-94A7-4606-B97F-4FC83E5A807AQ37246934-3A878774-5C1F-424C-B096-37CE25D60C93Q37278001-F59E6063-C406-4344-875C-04E4C26CDF22Q37346203-9EDF7866-30D3-4693-AF04-D62040D85380Q37677416-37840742-0C51-4DD5-8B19-D81E3E3D06C8Q37772779-043146FB-AD39-4411-9112-B4649F11844BQ37937040-2CE23886-E9C7-4A07-B2D9-2209F2D9A779Q37984131-6AB6E4F2-C57B-4712-88B3-BE04651676B9Q38072118-FB1DA1C7-9BC1-4013-9326-BACCD6362A10
P2860
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@ast
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@en
type
label
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@ast
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@en
prefLabel
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@ast
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@en
P2093
P2860
P356
P1476
p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
@en
P2093
David S Rubenstein
Luis A Diaz
Paula Berkowitz
Simon Warren
P2860
P304
12855-12860
P356
10.1073/PNAS.0602973103
P407
P577
2006-08-14T00:00:00Z